The abstract is read at the publisher; the summary is JClub's.
Relaxin-3/RXFP1 signaling is upregulated in diabetic rat and human aortas and preserves the contractile phenotype of vascular smooth muscle cells by suppressing H3K18la-linked Egfr transcription.
- Why it matters: Diabetic vascular remodeling is driven by VSMC phenotypic switching, but the relaxin-3 pathway and its epigenetic transcriptional mechanism in this process were unclear.
- What they did: In a diabetic rat model, the study used high-glucose VSMC metabolomics plus RNA-seq and ChIP-seq to map relaxin-3/RXFP1 regulation, including H3K18la-dependent Egfr transcription.
- The result: Relaxin-3 treatment reduced glycolytic rate and lactate production, decreased histone lactylation, suppressed LDHA-driven lactate and H3K18la-mediated Egfr transcription, and blocked PKM2 nuclear translocation to prevent PKM2/β-catenin complex formation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.